| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| CR Group L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 99,979 shares
@ $0.25, valued at
$25k
Sold 62,258 shares
@ $0.25, valued at
$15.6k
Sold 19,996 shares
@ $0.25, valued at
$5k
Sold 67,767 shares
@ $0.25, valued at
$16.9k
|
|
| 09/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2023 |
4
| Bernard Thierry (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 1,550 options to buy
@ $0
Exercised 454 options to buy
@ $0 |
|
| 08/16/2023 |
4
| Saunders Ninfa (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 1,550 restricted stock units
@ $0
Exercised 454 restricted stock units
@ $0 |
|
| 08/16/2023 |
4
| Toft Robin (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 454 restricted stock units
@ $0 |
|
| 07/14/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/06/2023 |
4
| CR Group L.P. (10% Owner) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 19,334,277 shares
@ $0
Granted 12,039,660 shares
@ $0
Granted 3,866,855 shares
@ $0
Granted 13,105,006 shares
@ $0 |
|
| 07/06/2023 |
3
| CR Group L.P. (10% Owner) has filed a Form 3 on T2 Biosystems, Inc. |
| 04/06/2023 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 239 shares
@ $0.481, valued at
$115 |
|
| 04/05/2023 |
4/A
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 334 restricted stock units
@ $0 |
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2023 |
4
| Adams Laura Lee (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 732 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Giffin Brett A. (Chief Commercial Officer) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 537 shares
@ $0.65, valued at
$349.1
Exercised 1,333 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Sprague John M (CFO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 1,545 shares
@ $0.65, valued at
$1k
Sold 1,148 shares
@ $0.59, valued at
$677.3
Exercised 4,000 restricted stock units
@ $0
Exercised 2,914 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Gibbs Michael Terrence (General Counsel) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 2,145 shares
@ $0.65, valued at
$1.4k
Sold 1,585 shares
@ $0.59, valued at
$935.2
Exercised 4,000 restricted stock units
@ $0
Exercised 2,914 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Sperzel John J III (Chairman and CEO) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Sold 6,875 shares
@ $0.65, valued at
$4.5k
Exercised 6,667 shares
@ $0
Sold 2,898 shares
@ $0.59, valued at
$1.7k
Exercised 16,000 restricted stock units
@ $0
Exercised 6,667 restricted stock units
@ $0 |
|
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2022 |
4
| Bernard Thierry (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 115,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| Elsbree David B (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 115,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| Saunders Ninfa (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 115,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| Toft Robin (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 115,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| Adams Laura Lee (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 115,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| CUMMING JOHN W (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 130,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| LIEBMAN SEYMOUR (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Granted 115,000 restricted stock units
@ $0 |
|
| 08/09/2022 |
4
| Toft Robin (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 22,727 restricted stock units
@ $0 |
|
| 08/09/2022 |
4
| Saunders Ninfa (Director) has filed a Form 4 on T2 Biosystems, Inc.|
Txns:
| Exercised 22,727 restricted stock units
@ $0 |
|
|